FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103848753> ?p ?o ?g. }

• W2103848753 endingPage "3279" @default.
• W2103848753 startingPage "3270" @default.
• W2103848753 abstract "Initial treatments for patients with differentiated thyroid cancer are supported primarily by single-institution, retrospective studies, with limited follow-up and low event rates. We report updated analyses of long-term outcomes after treatment in patients with differentiated thyroid cancer.The objective was to examine effects of initial therapies on outcomes.This was a prospective multi-institutional registry.A total of 4941 patients, median follow-up, 6 years, participated.Interventions included total/near-total thyroidectomy (T/NTT), postoperative radioiodine (RAI), and thyroid hormone suppression therapy (THST).Main outcome measures were overall survival (OS) and disease-free survival using product limit and proportional hazards analyses.Improved OS was noted in NTCTCS stage III patients who received RAI (risk ratio [RR], 0.66; P = .04) and stage IV patients who received both T/NTT and RAI (RR, 0.66 and 0.70; combined P = .049). In all stages, moderate THST (TSH maintained subnormal-normal) was associated with significantly improved OS (RR stages I-IV: 0.13, 0.09, 0.13, 0.33) and disease-free survival (RR stages I-III: 0.52, 0.40, 0.18); no additional survival benefit was achieved with more aggressive THST (TSH maintained undetectable-subnormal). This remained true, even when distant metastatic disease was diagnosed during follow-up. Lower initial stage and moderate THST were independent predictors of improved OS during follow-up years 1-3.We confirm previous findings that T/NTT followed by RAI is associated with benefit in high-risk patients, but not in low-risk patients. In contrast with earlier reports, moderate THST is associated with better outcomes across all stages, and aggressive THST may not be warranted even in patients diagnosed with distant metastatic disease during follow-up. Moderate THST continued at least 3 years after diagnosis may be indicated in high-risk patients." @default.
• W2103848753 created "2016-06-24" @default.
• W2103848753 creator A5000111683 @default.
• W2103848753 creator A5001548471 @default.
• W2103848753 creator A5004522280 @default.
• W2103848753 creator A5007121924 @default.
• W2103848753 creator A5019086649 @default.
• W2103848753 creator A5019420130 @default.
• W2103848753 creator A5030374801 @default.
• W2103848753 creator A5038090842 @default.
• W2103848753 creator A5043779853 @default.
• W2103848753 creator A5048856656 @default.
• W2103848753 creator A5052714864 @default.
• W2103848753 creator A5054886147 @default.
• W2103848753 creator A5062693491 @default.
• W2103848753 creator A5073085667 @default.
• W2103848753 creator A5087453647 @default.
• W2103848753 creator A5090422908 @default.
• W2103848753 date "2015-09-01" @default.
• W2103848753 modified "2023-10-18" @default.
• W2103848753 title "Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987–2012" @default.
• W2103848753 cites W1510228191 @default.
• W2103848753 cites W1548723165 @default.
• W2103848753 cites W1975344814 @default.
• W2103848753 cites W1981975876 @default.
• W2103848753 cites W1986798550 @default.
• W2103848753 cites W1990196512 @default.
• W2103848753 cites W1992692011 @default.
• W2103848753 cites W1999325012 @default.
• W2103848753 cites W2002331314 @default.
• W2103848753 cites W2016726618 @default.
• W2103848753 cites W2020840544 @default.
• W2103848753 cites W2023287870 @default.
• W2103848753 cites W2024017532 @default.
• W2103848753 cites W2032845025 @default.
• W2103848753 cites W2043226535 @default.
• W2103848753 cites W2046987218 @default.
• W2103848753 cites W2048654799 @default.
• W2103848753 cites W2048672164 @default.
• W2103848753 cites W2052806549 @default.
• W2103848753 cites W2057021887 @default.
• W2103848753 cites W2069392223 @default.
• W2103848753 cites W2091923260 @default.
• W2103848753 cites W2116542352 @default.
• W2103848753 cites W2121690051 @default.
• W2103848753 cites W2125517852 @default.
• W2103848753 cites W2134447925 @default.
• W2103848753 cites W2142884678 @default.
• W2103848753 cites W2148534774 @default.
• W2103848753 cites W2152497658 @default.
• W2103848753 cites W2155082105 @default.
• W2103848753 cites W2155384122 @default.
• W2103848753 cites W2158465969 @default.
• W2103848753 cites W2160393206 @default.
• W2103848753 cites W2163175491 @default.
• W2103848753 cites W2165844218 @default.
• W2103848753 cites W2168315834 @default.
• W2103848753 cites W2169531519 @default.
• W2103848753 cites W2335515807 @default.
• W2103848753 cites W4231667321 @default.
• W2103848753 cites W4233489284 @default.
• W2103848753 cites W4362127578 @default.
• W2103848753 doi "https://doi.org/10.1210/jc.2015-1346" @default.
• W2103848753 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5393522" @default.
• W2103848753 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26171797" @default.
• W2103848753 hasPublicationYear "2015" @default.
• W2103848753 type Work @default.
• W2103848753 sameAs 2103848753 @default.
• W2103848753 citedByCount "131" @default.
• W2103848753 countsByYear W21038487532015 @default.
• W2103848753 countsByYear W21038487532016 @default.
• W2103848753 countsByYear W21038487532017 @default.
• W2103848753 countsByYear W21038487532018 @default.
• W2103848753 countsByYear W21038487532019 @default.
• W2103848753 countsByYear W21038487532020 @default.
• W2103848753 countsByYear W21038487532021 @default.
• W2103848753 countsByYear W21038487532022 @default.
• W2103848753 countsByYear W21038487532023 @default.
• W2103848753 crossrefType "journal-article" @default.
• W2103848753 hasAuthorship W2103848753A5000111683 @default.
• W2103848753 hasAuthorship W2103848753A5001548471 @default.
• W2103848753 hasAuthorship W2103848753A5004522280 @default.
• W2103848753 hasAuthorship W2103848753A5007121924 @default.
• W2103848753 hasAuthorship W2103848753A5019086649 @default.
• W2103848753 hasAuthorship W2103848753A5019420130 @default.
• W2103848753 hasAuthorship W2103848753A5030374801 @default.
• W2103848753 hasAuthorship W2103848753A5038090842 @default.
• W2103848753 hasAuthorship W2103848753A5043779853 @default.
• W2103848753 hasAuthorship W2103848753A5048856656 @default.
• W2103848753 hasAuthorship W2103848753A5052714864 @default.
• W2103848753 hasAuthorship W2103848753A5054886147 @default.
• W2103848753 hasAuthorship W2103848753A5062693491 @default.
• W2103848753 hasAuthorship W2103848753A5073085667 @default.
• W2103848753 hasAuthorship W2103848753A5087453647 @default.
• W2103848753 hasAuthorship W2103848753A5090422908 @default.
• W2103848753 hasBestOaLocation W21038487531 @default.
• W2103848753 hasConcept C126322002 @default.
• W2103848753 hasConcept C141071460 @default.

• next